If U.S. Bankruptcy Judge Robert Drain allows nine objecting states to opt out of a $4.5 billion settlement deal, the Sackler family—founders of Purdue Pharma—would not agree to it.

That was among the messages delivered in testimony Wednesday by Richard Sackler, former chairman and president of Purdue Pharma, a privately held company based in Stamford, Connecticut, during a hearing on the proposed settlement involving his family members and the drug company in the U.S. Bankruptcy Court for the Southern District of New York.